Solitary Fibrous Tumor Treatment Market (Treatment: Surgery, Radiation Therapy, and Adjuvant Chemotherapy; and End-user: Ambulatory Surgical Centers, Hospitals, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2030

The global Solitary Fibrous Tumor Treatment market gathered revenue around USD 40.5 Million in 2021 and market is set to grow USD 65.3 Million by the end of 2030 and is estimated to expand at a modest CAGR of 4.5% during the prediction period 2022 to 2030.

Growth Factors:

Solitary fibrous tumor (SFT) is a rare tumor of mesenchymal origin that accounts for less than 2% of all soft tissue masses. Initially identified in the pleura, SFT has been identified in multiple anatomic locations and can arise anywhere in the body. These tumors occur equally in both men and women, most frequently in the 6th and 7th decades of life.

Report Scope of the Solitary Fibrous Tumor Treatment Market

Improved Diagnostic Procedures to Drive Global Market

In the past few decades, sustained advances through research & technology have led to more reliable methods for differentiating this distinct soft tissue tumor. Advances, specifically in immunohistochemistry and molecular diagnostics, have identified CD34 as the most consistent marker in solitary fibrous tumor. More recently, the discovery of the NAB2-STAT6 fusion gene has led to more precise diagnosis of solitary fibrous tumor. Hence, improvement and new development of diagnostic procedures are anticipated to drive the global solitary fibrous tumor treatment market.

High Cost of Treatment to Hamper Global Market

Several studies have suggested that people with rare diseases face higher healthcare costs than those with common diseases. Solitary fibrous tumor is a very rare disease. Treatment involves surgery and therapies such as radiation therapy and chemotherapy. However, high cost of therapies and other immunotherapies is expected to deter patients from availing these treatments.

Surgery to be Remain Treatment Method

The global solitary fibrous tumor treatment market has been segmented based on treatment and end-user. In terms of treatment, the global solitary fibrous tumor market has been classified into surgery, radiation therapy, and adjuvant chemotherapy. The surgery segment is likely to account for major share of the global market by 2031, due to increase in demand for surgery, as surgical management has been the mainstay treatment for solitary fibrous tumor.

Hospitals to be Key End-user

In terms of end-user, the global solitary fibrous tumor treatment market has been divided into hospitals, ambulatory surgical centers, and others. The hospitals segment is projected to expand at a high CAGR during the forecast period due to rise in patient preference for all types of treatment facility under one roof.

North America to Dominate Global Market

The global solitary fibrous tumor treatment market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global solitary fibrous tumor treatment market in 2020, followed by Europe. North America accounted for major share of the global solitary fibrous tumor treatment market in 2020 due to high awareness and increase in demand for disease risk assessment services for cancer treatment.

The solitary fibrous tumor treatment market in Asia Pacific is projected to expand at a high CAGR from 2022 to 2030. Rise in number of patients, high healthcare expenditure, and geographic expansion by major players, especially in China and India, are anticipated to drive the solitary fibrous tumor treatment market in the region.

Some of the prominent players in the Solitary Fibrous Tumor Treatment Market include:

• Pfizer, Inc.
• F. Hoffmann-La Roche Ltd.
• Eli Lilly and Company
• Bayer AG
• Novartis AG

Segments Covered in the Report

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for the period of 2017 to 2030 and covers subsequent region in its scope:

Global Solitary Fibrous Tumor Treatment Market: Segmentation

• Solitary Fibrous Tumor Treatment Market, by Treatment
• Surgery
• Radiation Therapy
• Adjuvant Chemotherapy
• Solitary Fibrous Tumor Treatment Market, by End-user
• Hospitals
• Ambulatory Surgical Clinics
• Others

By Geography

North America

• U.S.
• Canada

Europe

• Germany
• France
• United Kingdom
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Southeast Asia
• Rest of Asia Pacific

Latin America

• Brazil
• Rest of Latin America

Middle East & Africa (MEA)

• GCC
• North Africa
• South Africa
• Rest of Middle East & Africa

Key Points Covered in Solitary Fibrous Tumor Treatment Market Study:

• Growth of Solitary Fibrous Tumor Treatment in 2022
• Market Estimates and Forecasts (2017-2030)
•  Brand Share and Market Share Analysis
•  Key Drivers and Restraints Shaping Market Growth
•  Segment-wise, Country-wise, and Region-wise Analysis
•  Competition Mapping and Benchmarking
•  Recommendation on Key Winning Strategies
•  COVID-19 Impact on Demand for Solitary Fibrous Tumor Treatment and How to Navigate
•  Key Product Innovations and Regulatory Climate
•  Solitary Fibrous Tumor Treatment Consumption Analysis
•  Solitary Fibrous Tumor Treatment Production Analysis
•  Solitary Fibrous Tumor Treatment and Management